Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;3(1):82-3.
doi: 10.4103/0976-500X.92510.

Belatacept: Good, but not good enough?

Sreejith Parameswaran  1 , R P Swaminathan
Affiliations

Belatacept: Good, but not good enough?

Sreejith Parameswaran et al. J Pharmacol Pharmacother. 2012 Jan.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Authors' reply.
    Melvin G, Sandhiya S, Subraja K. Melvin G, et al. J Pharmacol Pharmacother. 2012 Jan;3(1):83-4. doi: 10.4103/0976-500x.92511. J Pharmacol Pharmacother. 2012. PMID: 22368435 Free PMC article. No abstract available.

References

    1. George M, Selvarajan S, Kumaresan S. Belatacept: A worthy alternative to cyclosporine? J Pharmacol Pharmacother. 2012;3:89–91. - PMC - PubMed
    1. Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) Am J Transplant. 2010;10:535–46. - PubMed
    1. Webster AC, Taylor RR, Chapman JR, Craig JC. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. 2005;4:CD003961. - PubMed
    1. Sharma AK, Gupta R, Tolani SL, Rathi GL, Gupta HP. Evaluation of socioeconomic factors in noncompliance in renal transplantation. Transplant Proc. 2000;32:1864. - PubMed

LinkOut - more resources